• With over 20 approved products and several under development, the Avastin® biosimilars market is projected to witness noteworthy growth over the coming years, claims Roots Analysis

    In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved

    Roots Analysis has announced the addition of the “Avastin® (Bevacizumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.

    Biosimilars of bevacizumab are currently approved / being developed to treat colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. Experts believe that a strong biosimilar portfolio is equivalent to a blockbuster product, at least for companies with marketing power and reach; as a result, several big pharma players are actively involved in this upcoming category of healthcare products.


    Key Report Highlights

    In 2020, Roche lost more than USD 6 billion in international revenues due to biosimilar competition
    This substantial erosion in sales is evidence of the market capturing potential of biosimilars, despite the numerous barriers that exist both in the United States and internationally, which prevent such drugs from challenging their much higher-priced originator products

    Over 40 companies are currently involved in the development of Avastin® biosimilars
    It is worth highlighting that there are 45+ products, representing 9 unique biosimilars of bevacizumab, which have either been approved / launched in various regions of the world. Some of the latest additions to the growing list of bevacizumab biosimilar approvals in the EU, include ALYMSYS® (2021) and AYBINTIO® (2020).

    Several biosimilar candidates are presently under development across 130+ trials, in various global regions
    Many of such investigational leads are in the late stages of development and for several product candidates, new drug applications (NDAs) / marketing authorization applications (MAAs) have already been submitted to regulators in different nations across the world.

    Partnership activity, related to biosimilars of bevacizumab, has grown at a gradual pace since 2009
    Most of the deals inked between companies in the same region were product development agreements; on the other hand, the majority of partnerships involving companies across different geographical regions were focused on product distribution.

    To request a sample copy / brochure of this report, please visit this
    https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships/request-sample.html

    Key Questions Answered
     Who are the key players engaged in the development of biosimilars of bevacizumab?
     In which global marketplaces are Avastin® biosimilars currently available?
     What is the current scenario within the clinical development landscape of bevacizumab biosimilars?
     How many biosimilar development programs have and what were the reasons?
     Who are the key players involved in the commercialization of bevacizumab biosimilars across the world?
     What kind of partnerships have been inked between stakeholders in this domain?

    The research includes detailed profiles of companies having approved / launched biosimilars across different global regions; each profile features an overview of the company, information related to its current portfolio of bevacizumab biosimilars, financial information (if available) and key product related specifications.
     Abbott Laboratories
     Alkem Laboratories
     Amgen
     AryoGen Pharmed
     Biocad
     Cadila Pharmaceuticals
     Centus Biotherapeutics
     Dr Reddy’s Laboratories
     Emcure
     Hetero Healthcare
     Innovent Biologics
     Intas Pharmaceuticals
     Laboratorio Elea
     Lupin
     mAbxience
     Pfizer
     Qilu Pharmaceutical
     Reliance Life Sciences
     Samsung Bioepis
     Shanghai Henlius biotech
     Viatris


    You may also be interested in the following titles:
    1. HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships
    2. Herceptin® (Trastuzumab) Biosimilars – Pipeline Review and Partnerships

    For more information, please click on the following link:
    https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html

    You may also be interested in the following reports:
    1. Clinical Trials Software Market
    2. Precision Medicine Software Developers Market
    3. Investor Series: Opportunities in the Telehealth Market
    4. DNA Data Storage Market


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    With over 20 approved products and several under development, the Avastin® biosimilars market is projected to witness noteworthy growth over the coming years, claims Roots Analysis In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved Roots Analysis has announced the addition of the “Avastin® (Bevacizumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings. Biosimilars of bevacizumab are currently approved / being developed to treat colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. Experts believe that a strong biosimilar portfolio is equivalent to a blockbuster product, at least for companies with marketing power and reach; as a result, several big pharma players are actively involved in this upcoming category of healthcare products. Key Report Highlights In 2020, Roche lost more than USD 6 billion in international revenues due to biosimilar competition This substantial erosion in sales is evidence of the market capturing potential of biosimilars, despite the numerous barriers that exist both in the United States and internationally, which prevent such drugs from challenging their much higher-priced originator products Over 40 companies are currently involved in the development of Avastin® biosimilars It is worth highlighting that there are 45+ products, representing 9 unique biosimilars of bevacizumab, which have either been approved / launched in various regions of the world. Some of the latest additions to the growing list of bevacizumab biosimilar approvals in the EU, include ALYMSYS® (2021) and AYBINTIO® (2020). Several biosimilar candidates are presently under development across 130+ trials, in various global regions Many of such investigational leads are in the late stages of development and for several product candidates, new drug applications (NDAs) / marketing authorization applications (MAAs) have already been submitted to regulators in different nations across the world. Partnership activity, related to biosimilars of bevacizumab, has grown at a gradual pace since 2009 Most of the deals inked between companies in the same region were product development agreements; on the other hand, the majority of partnerships involving companies across different geographical regions were focused on product distribution. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships/request-sample.html Key Questions Answered  Who are the key players engaged in the development of biosimilars of bevacizumab?  In which global marketplaces are Avastin® biosimilars currently available?  What is the current scenario within the clinical development landscape of bevacizumab biosimilars?  How many biosimilar development programs have and what were the reasons?  Who are the key players involved in the commercialization of bevacizumab biosimilars across the world?  What kind of partnerships have been inked between stakeholders in this domain? The research includes detailed profiles of companies having approved / launched biosimilars across different global regions; each profile features an overview of the company, information related to its current portfolio of bevacizumab biosimilars, financial information (if available) and key product related specifications.  Abbott Laboratories  Alkem Laboratories  Amgen  AryoGen Pharmed  Biocad  Cadila Pharmaceuticals  Centus Biotherapeutics  Dr Reddy’s Laboratories  Emcure  Hetero Healthcare  Innovent Biologics  Intas Pharmaceuticals  Laboratorio Elea  Lupin  mAbxience  Pfizer  Qilu Pharmaceutical  Reliance Life Sciences  Samsung Bioepis  Shanghai Henlius biotech  Viatris You may also be interested in the following titles: 1. HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships 2. Herceptin® (Trastuzumab) Biosimilars – Pipeline Review and Partnerships For more information, please click on the following link: https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html You may also be interested in the following reports: 1. Clinical Trials Software Market 2. Precision Medicine Software Developers Market 3. Investor Series: Opportunities in the Telehealth Market 4. DNA Data Storage Market About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    Request Sample - Avastin® (Bevacizumab) Biosimilars - Pipeline Review and Partnerships
    AvastinR (Bevacizumab) Biosimilars - Pipeline Review and Partnerships report features an extensive study of the current market landscape and future potential...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • Teleradiology Services – The steadily growing volume of medical imaging data

    The “Teleradiology Services Market, report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of teleradiology solutions in the diagnostic imaging industry, till 2030. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

    Teleradiology is a branch of telemedicine that uses telecommunication systems for the transmission of radiological images from one location to another. Additionally, it helps radiologists in interpreting various types of images, such as digitized X-rays, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound and nuclear medicine studies, remotely. The teleradiology process generally requires three important monads, namely an image sending station, a transmission network and a receiving image station; all the aforementioned locations should further be equipped with a high-quality display screen, well-suited for clinical objectives. A computer program must also be installed at imaging stations in order to ease out the process of sending and receiving diagnostic images.

    To request a sample report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-sample.html

     Picture Archiving and Communication System (PACS):
    PACS is a medical imaging system that is used to store, retrieve, manage, and distribute medical images. It is worth mentioning that this method eliminates the need for manual storage, retrieval, and transmission of sensitive health data of patients. Most of the PACS are connected to off-site
    cloud servers, which makes the storage easier and medical data accessible, essentially from anywhere around the world

     Radiological Information System (RIS):
    RIS is a teleradiology software system that is used to manage data for medical images. Additionally, it can be customized to store various patient related information, such as patient scheduling, patient total radiation dose, workflow management and list management. RIS improves workflow and streamlines processes, while systems, such as PACS, provide storage and a long-term option for the management of patient information. It is worth mentioning that, both RIS and PACS act as two complementary systems which are usually used in conjugation in most of the radiology clinics.

     Clinical Information System (CIS):
    CIS is a computerized system that organizes, stores and validates medical information of a patient. Additionally, it maintains a record of health history, prescriptions, and doctor's notes. Further, the built-in safety features of this system minimize the chance of errors in the patient data to a large extent.

    To order customize report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-customization.html

    Owing to numerous advantages offered by teleradiology solutions, this domain has gained a significant amount of interest from both patients, as well as radiologists. The rising interest in this domain can be attributed to following reasons:
     High Demand:
    The demand for teleradiology solutions has increased manifold, over the several years. According to the American College of Radiology, the market for MRI, CT scan and interventional radiology services has increased at an average rate of 7.3% per year, during the period 2009-2021. Further, post the onset of the COVID-19 pandemic, the demand for teleradiology services has increased significantly in the healthcare market.

     Shortage of Radiologists:
    According to Charles Williams, chairman of the American College of Radiology's Commission on Human Resources, the number of new radiologists entering in this domain has increased at a
    rate of only 2% per year. This rate is less, as compared to the rise in demand, indicating a shortage of radiologists in the current system. Experts believe that teleradiology has the potential to help overcome the challenges related to the shortage of radiologists.

     Remote Reporting:
    Post the onset of the COVID-19 pandemic, there has been a significant increase in the adoption rate of teleradiology solutions for the interpretation of diagnostic images. This can be attributed to the fact that patients are still reluctant to visit hospitals, owing to the COVID-19 pandemic.


     Early Detection of Diseases:
    Teleradiology services can help in early detection of a fatal disease. Therefore, rapid reporting becomes an extremely important factor, especially in urgent care / emergency centers, and during night hours. It is worth mentioning that reporting of such cases is made faster by outsourcing the radiology reporting to other regions, including Australia, Europe and some Asian countries (such as India).



     High Costs:
    Currently, diagnostic imaging is considered as one of the fastest growing field. However, due to the high costs associated with conventional radiology image interpretation methodologies, teleradiology is seen as an affordable choice. This can be attributed to the fact that teleradiology solutions save travel costs (for both radiologists and patients) and expenditures of teleradiologists as they can work remotely

    For more information, please click on the following link:
    https://www.rootsanalysis.com/reports/teraradiology-services-market.html

    You may also be interested in the following reports:
    1. Clinical Trials Software Market
    2. Precision Medicine Software Developers Market
    3. Investor Series: Opportunities in the Telehealth Market
    4. DNA Data Storage Market


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    Teleradiology Services – The steadily growing volume of medical imaging data The “Teleradiology Services Market, report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of teleradiology solutions in the diagnostic imaging industry, till 2030. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Teleradiology is a branch of telemedicine that uses telecommunication systems for the transmission of radiological images from one location to another. Additionally, it helps radiologists in interpreting various types of images, such as digitized X-rays, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound and nuclear medicine studies, remotely. The teleradiology process generally requires three important monads, namely an image sending station, a transmission network and a receiving image station; all the aforementioned locations should further be equipped with a high-quality display screen, well-suited for clinical objectives. A computer program must also be installed at imaging stations in order to ease out the process of sending and receiving diagnostic images. To request a sample report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-sample.html  Picture Archiving and Communication System (PACS): PACS is a medical imaging system that is used to store, retrieve, manage, and distribute medical images. It is worth mentioning that this method eliminates the need for manual storage, retrieval, and transmission of sensitive health data of patients. Most of the PACS are connected to off-site cloud servers, which makes the storage easier and medical data accessible, essentially from anywhere around the world  Radiological Information System (RIS): RIS is a teleradiology software system that is used to manage data for medical images. Additionally, it can be customized to store various patient related information, such as patient scheduling, patient total radiation dose, workflow management and list management. RIS improves workflow and streamlines processes, while systems, such as PACS, provide storage and a long-term option for the management of patient information. It is worth mentioning that, both RIS and PACS act as two complementary systems which are usually used in conjugation in most of the radiology clinics.  Clinical Information System (CIS): CIS is a computerized system that organizes, stores and validates medical information of a patient. Additionally, it maintains a record of health history, prescriptions, and doctor's notes. Further, the built-in safety features of this system minimize the chance of errors in the patient data to a large extent. To order customize report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-customization.html Owing to numerous advantages offered by teleradiology solutions, this domain has gained a significant amount of interest from both patients, as well as radiologists. The rising interest in this domain can be attributed to following reasons:  High Demand: The demand for teleradiology solutions has increased manifold, over the several years. According to the American College of Radiology, the market for MRI, CT scan and interventional radiology services has increased at an average rate of 7.3% per year, during the period 2009-2021. Further, post the onset of the COVID-19 pandemic, the demand for teleradiology services has increased significantly in the healthcare market.  Shortage of Radiologists: According to Charles Williams, chairman of the American College of Radiology's Commission on Human Resources, the number of new radiologists entering in this domain has increased at a rate of only 2% per year. This rate is less, as compared to the rise in demand, indicating a shortage of radiologists in the current system. Experts believe that teleradiology has the potential to help overcome the challenges related to the shortage of radiologists.  Remote Reporting: Post the onset of the COVID-19 pandemic, there has been a significant increase in the adoption rate of teleradiology solutions for the interpretation of diagnostic images. This can be attributed to the fact that patients are still reluctant to visit hospitals, owing to the COVID-19 pandemic.  Early Detection of Diseases: Teleradiology services can help in early detection of a fatal disease. Therefore, rapid reporting becomes an extremely important factor, especially in urgent care / emergency centers, and during night hours. It is worth mentioning that reporting of such cases is made faster by outsourcing the radiology reporting to other regions, including Australia, Europe and some Asian countries (such as India).  High Costs: Currently, diagnostic imaging is considered as one of the fastest growing field. However, due to the high costs associated with conventional radiology image interpretation methodologies, teleradiology is seen as an affordable choice. This can be attributed to the fact that teleradiology solutions save travel costs (for both radiologists and patients) and expenditures of teleradiologists as they can work remotely For more information, please click on the following link: https://www.rootsanalysis.com/reports/teraradiology-services-market.html You may also be interested in the following reports: 1. Clinical Trials Software Market 2. Precision Medicine Software Developers Market 3. Investor Series: Opportunities in the Telehealth Market 4. DNA Data Storage Market About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    Request Sample - Teleradiology Services Market | Remote Diagnosis | Online Health | Telemedicine | Medical Imaging | Market Size | 2030
    Driven by rising demand for remote patient diagnosis, the teleradiology services market is anticipated to grow at an annualized rate of about 17%, till 2030...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • TELERADIOLOGY SERVICES – HAS CREATED THE NEED FOR REMOTE PATIENT DIAGNOSIS

    The “Teleradiology Services Market, report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of teleradiology solutions in the diagnostic imaging industry, till 2030. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

    Teleradiology is a branch of telemedicine that uses telecommunication systems for the transmission of radiological images from one location to another. Additionally, it helps radiologists in interpreting various types of images, such as digitized X-rays, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound and nuclear medicine studies, remotely. The teleradiology process generally requires three important monads, namely an image sending station, a transmission network and a receiving image station; all the aforementioned locations should further be equipped with a high-quality display screen, well-suited for clinical objectives. A computer program must also be installed at imaging stations in order to ease out the process of sending and receiving diagnostic images.

    To request a sample report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-sample.html

     Picture Archiving and Communication System (PACS):
    PACS is a medical imaging system that is used to store, retrieve, manage, and distribute medical images. It is worth mentioning that this method eliminates the need for manual storage, retrieval, and transmission of sensitive health data of patients. Most of the PACS are connected to off-site
    cloud servers, which makes the storage easier and medical data accessible, essentially from anywhere around the world

     Radiological Information System (RIS):
    RIS is a teleradiology software system that is used to manage data for medical images. Additionally, it can be customized to store various patient related information, such as patient scheduling, patient total radiation dose, workflow management and list management. RIS improves workflow and streamlines processes, while systems, such as PACS, provide storage and a long-term option for the management of patient information. It is worth mentioning that, both RIS and PACS act as two complementary systems which are usually used in conjugation in most of the radiology clinics.

     Clinical Information System (CIS):
    CIS is a computerized system that organizes, stores and validates medical information of a patient. Additionally, it maintains a record of health history, prescriptions, and doctor's notes. Further, the built-in safety features of this system minimize the chance of errors in the patient data to a large extent.

    To order customize report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-customization.html

    Owing to numerous advantages offered by teleradiology solutions, this domain has gained a significant amount of interest from both patients, as well as radiologists. The rising interest in this domain can be attributed to following reasons:
     High Demand:
    The demand for teleradiology solutions has increased manifold, over the several years. According to the American College of Radiology, the market for MRI, CT scan and interventional radiology services has increased at an average rate of 7.3% per year, during the period 2009-2021. Further, post the onset of the COVID-19 pandemic, the demand for teleradiology services has increased significantly in the healthcare market.

     Shortage of Radiologists:
    According to Charles Williams, chairman of the American College of Radiology's Commission on Human Resources, the number of new radiologists entering in this domain has increased at a
    rate of only 2% per year. This rate is less, as compared to the rise in demand, indicating a shortage of radiologists in the current system. Experts believe that teleradiology has the potential to help overcome the challenges related to the shortage of radiologists.

     Remote Reporting:
    Post the onset of the COVID-19 pandemic, there has been a significant increase in the adoption rate of teleradiology solutions for the interpretation of diagnostic images. This can be attributed to the fact that patients are still reluctant to visit hospitals, owing to the COVID-19 pandemic.


     Early Detection of Diseases:
    Teleradiology services can help in early detection of a fatal disease. Therefore, rapid reporting becomes an extremely important factor, especially in urgent care / emergency centers, and during night hours. It is worth mentioning that reporting of such cases is made faster by outsourcing the radiology reporting to other regions, including Australia, Europe and some Asian countries (such as India).



     High Costs:
    Currently, diagnostic imaging is considered as one of the fastest growing field. However, due to the high costs associated with conventional radiology image interpretation methodologies, teleradiology is seen as an affordable choice. This can be attributed to the fact that teleradiology solutions save travel costs (for both radiologists and patients) and expenditures of teleradiologists as they can work remotely

    For more information, please click on the following link:
    https://www.rootsanalysis.com/reports/teraradiology-services-market.html

    You may also be interested in the following reports:
    1. Clinical Trials Software Market
    2. Precision Medicine Software Developers Market
    3. Investor Series: Opportunities in the Telehealth Market
    4. DNA Data Storage Market


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    TELERADIOLOGY SERVICES – HAS CREATED THE NEED FOR REMOTE PATIENT DIAGNOSIS The “Teleradiology Services Market, report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of teleradiology solutions in the diagnostic imaging industry, till 2030. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Teleradiology is a branch of telemedicine that uses telecommunication systems for the transmission of radiological images from one location to another. Additionally, it helps radiologists in interpreting various types of images, such as digitized X-rays, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound and nuclear medicine studies, remotely. The teleradiology process generally requires three important monads, namely an image sending station, a transmission network and a receiving image station; all the aforementioned locations should further be equipped with a high-quality display screen, well-suited for clinical objectives. A computer program must also be installed at imaging stations in order to ease out the process of sending and receiving diagnostic images. To request a sample report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-sample.html  Picture Archiving and Communication System (PACS): PACS is a medical imaging system that is used to store, retrieve, manage, and distribute medical images. It is worth mentioning that this method eliminates the need for manual storage, retrieval, and transmission of sensitive health data of patients. Most of the PACS are connected to off-site cloud servers, which makes the storage easier and medical data accessible, essentially from anywhere around the world  Radiological Information System (RIS): RIS is a teleradiology software system that is used to manage data for medical images. Additionally, it can be customized to store various patient related information, such as patient scheduling, patient total radiation dose, workflow management and list management. RIS improves workflow and streamlines processes, while systems, such as PACS, provide storage and a long-term option for the management of patient information. It is worth mentioning that, both RIS and PACS act as two complementary systems which are usually used in conjugation in most of the radiology clinics.  Clinical Information System (CIS): CIS is a computerized system that organizes, stores and validates medical information of a patient. Additionally, it maintains a record of health history, prescriptions, and doctor's notes. Further, the built-in safety features of this system minimize the chance of errors in the patient data to a large extent. To order customize report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-customization.html Owing to numerous advantages offered by teleradiology solutions, this domain has gained a significant amount of interest from both patients, as well as radiologists. The rising interest in this domain can be attributed to following reasons:  High Demand: The demand for teleradiology solutions has increased manifold, over the several years. According to the American College of Radiology, the market for MRI, CT scan and interventional radiology services has increased at an average rate of 7.3% per year, during the period 2009-2021. Further, post the onset of the COVID-19 pandemic, the demand for teleradiology services has increased significantly in the healthcare market.  Shortage of Radiologists: According to Charles Williams, chairman of the American College of Radiology's Commission on Human Resources, the number of new radiologists entering in this domain has increased at a rate of only 2% per year. This rate is less, as compared to the rise in demand, indicating a shortage of radiologists in the current system. Experts believe that teleradiology has the potential to help overcome the challenges related to the shortage of radiologists.  Remote Reporting: Post the onset of the COVID-19 pandemic, there has been a significant increase in the adoption rate of teleradiology solutions for the interpretation of diagnostic images. This can be attributed to the fact that patients are still reluctant to visit hospitals, owing to the COVID-19 pandemic.  Early Detection of Diseases: Teleradiology services can help in early detection of a fatal disease. Therefore, rapid reporting becomes an extremely important factor, especially in urgent care / emergency centers, and during night hours. It is worth mentioning that reporting of such cases is made faster by outsourcing the radiology reporting to other regions, including Australia, Europe and some Asian countries (such as India).  High Costs: Currently, diagnostic imaging is considered as one of the fastest growing field. However, due to the high costs associated with conventional radiology image interpretation methodologies, teleradiology is seen as an affordable choice. This can be attributed to the fact that teleradiology solutions save travel costs (for both radiologists and patients) and expenditures of teleradiologists as they can work remotely For more information, please click on the following link: https://www.rootsanalysis.com/reports/teraradiology-services-market.html You may also be interested in the following reports: 1. Clinical Trials Software Market 2. Precision Medicine Software Developers Market 3. Investor Series: Opportunities in the Telehealth Market 4. DNA Data Storage Market About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    Request Sample - Teleradiology Services Market | Remote Diagnosis | Online Health | Telemedicine | Medical Imaging | Market Size | 2030
    Driven by rising demand for remote patient diagnosis, the teleradiology services market is anticipated to grow at an annualized rate of about 17%, till 2030...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • Telehealth Market Share 2021 –Size, Growth, Future Trends, Challenges and Forecast to 2030

    The Telehealth Market titled report has been published by Absolute Markets Insights which is one of important additions and comprehensive to the market. It covers in-detailed research and analysis of key aspects of the Telehealth Market. Market analysts covers comprehensive information provided in this report is an overall analysis of the Telehealth Market, providing leading growth drivers, challenges, restraints, new trends, and opportunities. Current and Future revenue of the Telehealth Market is carefully analyzed and studied by market analysts. Market analysis and researchers have performed extensive analysis of the Telehealth Market with the help of research methodologies such as Regional, SWOT and Porter's analysis. They are provided with accurate and reliable market data and useful recommendations that objective to help key players gain insight into the overall presence and future market scenarios. This report also covers in-depth research on potential segments including types, applications, and end users and their contributions to the overall market size.

    Telehealth Market was estimated to grow at 14.97% CAGR during the forecast period due to the rising need for optimum ailment detection and treatment

    Some of the players operating in the Telehealth market are Cisco Systems Inc., Life Care Solutions, Siemens Healthcare, Robert Bosch Healthcare amongst others
    Healthcare costs are observed to be increasing globally due to the growing demand for new medicines, innovative techniques, lifestyle factors, fast diagnosis, etc. from consumers. This leads to increased expenses for hospitals and doctors that in exchange charge private payers significantly higher rates for the same facilities and services. Telehealth reduced the cost of healthcare and improved efficiency, by improving chronic disease management, reducing travel times, shared medical personnel, and increasingly reducing hospital spending. Therefore, due to all of the above factors, the Telehealth Market is expected to increase significantly over the forecast period.

    Get more information of this report @ https://www.absolutemarketsinsights.com/reports/Telehealth-Market-2019-2027-469

    COVID-19 Impact Analysis:
    This Telehealth Market research study provides a comprehensive overview of the market. To begin, it provides an overview of the market, including market size, share, growth, and dynamics. Later, it shows definition, a review of key market developments, a thorough aggressive evaluation, and a budgetary analysis. The research covers both current and prospective market conditions.
    The research report highlights the market’s current and potential key opportunities. The market’s upcoming problems and obstacles are also included in this research report, assisting the customer in succeeding in the market.

    Segmentation of Telehealth Market:
    • By Component
    o Hardware
    o Services
    o Software
    • By Delivery
    o On demand
    o Web based
    o Cloud
    • By End User
    o Healthcare Providers
    o Patients and Payer
    • By Geography
    o North America
     U.S
     Canada
     Mexico
     Rest of North America
    o Europe
     France
     The UK
     Spain
     Germany
     Italy
     Nordic Countries
     Denmark
     Finland
     Iceland
     Sweden
     Norway
     Benelux Union
     Belgium
     The Netherlands
     Luxembourg
     Rest of Europe
    o Asia Pacific
     China
     Japan
     India
     New Zealand
     Australia
     South Korea
     Southeast Asia
     Indonesia
     Thailand
     Malaysia
     Singapore
     Rest of Southeast Asia
     Rest of Asia Pacific
    o Middle East and Africa
     Saudi Arabia
     UAE
     Egypt
     Kuwait
     South Africa
     Rest of Middle East & Africa
    o Latin America
     Brazil
     Argentina
     Rest of Latin America

    The research provides answers to the following key questions:
    1. What is the projected market size of the Telehealth Market by 2030?
    2. What will the normal share of the industry as a whole be for years to come?
    3. What are the significant components and restraints in the development of the Telehealth Market across varying geographies?
    4. Who are the major sellers expected to dominate the market for the 2021 to 2030 evaluation period?
    5. What are the moving and upcoming advancements that are expected to influence the advancement of the Telehealth Market?
    6. What are the development techniques received by major market sellers to stay ahead of the curve?

    Related Report@
    https://www.absolutemarketsinsights.com/reports/Chronic-Low-Back-Pain-Market-2019-2027-313
    https://www.absolutemarketsinsights.com/reports/Telehealth-for-Women%E2%80%99s-Reproductive-and-Sexual-Health-Market-2019-2027-289
    https://www.absolutemarketsinsights.com/reports/Global-Diagnostic-Catheter-Market-2019-2027-261

    Contact us:
    Contact Name: Shreyas Tanna
    Phone: +91-740-024-2424
    Company: Absolute Markets Insights
    Email Id: sales@absolutemarketsinsights.com
    Telehealth Market Share 2021 –Size, Growth, Future Trends, Challenges and Forecast to 2030 The Telehealth Market titled report has been published by Absolute Markets Insights which is one of important additions and comprehensive to the market. It covers in-detailed research and analysis of key aspects of the Telehealth Market. Market analysts covers comprehensive information provided in this report is an overall analysis of the Telehealth Market, providing leading growth drivers, challenges, restraints, new trends, and opportunities. Current and Future revenue of the Telehealth Market is carefully analyzed and studied by market analysts. Market analysis and researchers have performed extensive analysis of the Telehealth Market with the help of research methodologies such as Regional, SWOT and Porter's analysis. They are provided with accurate and reliable market data and useful recommendations that objective to help key players gain insight into the overall presence and future market scenarios. This report also covers in-depth research on potential segments including types, applications, and end users and their contributions to the overall market size. Telehealth Market was estimated to grow at 14.97% CAGR during the forecast period due to the rising need for optimum ailment detection and treatment Some of the players operating in the Telehealth market are Cisco Systems Inc., Life Care Solutions, Siemens Healthcare, Robert Bosch Healthcare amongst others Healthcare costs are observed to be increasing globally due to the growing demand for new medicines, innovative techniques, lifestyle factors, fast diagnosis, etc. from consumers. This leads to increased expenses for hospitals and doctors that in exchange charge private payers significantly higher rates for the same facilities and services. Telehealth reduced the cost of healthcare and improved efficiency, by improving chronic disease management, reducing travel times, shared medical personnel, and increasingly reducing hospital spending. Therefore, due to all of the above factors, the Telehealth Market is expected to increase significantly over the forecast period. Get more information of this report @ https://www.absolutemarketsinsights.com/reports/Telehealth-Market-2019-2027-469 COVID-19 Impact Analysis: This Telehealth Market research study provides a comprehensive overview of the market. To begin, it provides an overview of the market, including market size, share, growth, and dynamics. Later, it shows definition, a review of key market developments, a thorough aggressive evaluation, and a budgetary analysis. The research covers both current and prospective market conditions. The research report highlights the market’s current and potential key opportunities. The market’s upcoming problems and obstacles are also included in this research report, assisting the customer in succeeding in the market. Segmentation of Telehealth Market: • By Component o Hardware o Services o Software • By Delivery o On demand o Web based o Cloud • By End User o Healthcare Providers o Patients and Payer • By Geography o North America  U.S  Canada  Mexico  Rest of North America o Europe  France  The UK  Spain  Germany  Italy  Nordic Countries  Denmark  Finland  Iceland  Sweden  Norway  Benelux Union  Belgium  The Netherlands  Luxembourg  Rest of Europe o Asia Pacific  China  Japan  India  New Zealand  Australia  South Korea  Southeast Asia  Indonesia  Thailand  Malaysia  Singapore  Rest of Southeast Asia  Rest of Asia Pacific o Middle East and Africa  Saudi Arabia  UAE  Egypt  Kuwait  South Africa  Rest of Middle East & Africa o Latin America  Brazil  Argentina  Rest of Latin America The research provides answers to the following key questions: 1. What is the projected market size of the Telehealth Market by 2030? 2. What will the normal share of the industry as a whole be for years to come? 3. What are the significant components and restraints in the development of the Telehealth Market across varying geographies? 4. Who are the major sellers expected to dominate the market for the 2021 to 2030 evaluation period? 5. What are the moving and upcoming advancements that are expected to influence the advancement of the Telehealth Market? 6. What are the development techniques received by major market sellers to stay ahead of the curve? Related Report@ https://www.absolutemarketsinsights.com/reports/Chronic-Low-Back-Pain-Market-2019-2027-313 https://www.absolutemarketsinsights.com/reports/Telehealth-for-Women%E2%80%99s-Reproductive-and-Sexual-Health-Market-2019-2027-289 https://www.absolutemarketsinsights.com/reports/Global-Diagnostic-Catheter-Market-2019-2027-261 Contact us: Contact Name: Shreyas Tanna Phone: +91-740-024-2424 Company: Absolute Markets Insights Email Id: sales@absolutemarketsinsights.com
    Telehealth Market by Component, Delivery Model, End-Customers, Regions | Absolute Markets Insights
    [402 Pages] Telehealth Market by Component (Hardware, Services and Software), Delivery Model (On -Premise, Web and Cloud), End-Customers (Healthcare Providers, Patients and Payers); By Region (U.S., Canada, Mexico, Rest of North America, UK, France, Germany, Italy, Spain, Benelux Union, Nordic Countries , Rest of Europe, China, Japan, India, South Korea, Singapore, Philippines, Indonesia, Thailand, Malaysia, Vietnam, Rest of Southeast Asia, Brazil, Argentina Rest of Latin America, GCC countries, Southern Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
    WWW.ABSOLUTEMARKETSINSIGHTS.COM
    0 Comments 0 Shares

No results to show

No results to show

No results to show

No results to show

Sponsored